Q1 2024 Holdings
Filed 2024-05-15 | 87 holdings | $8.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Incyte Corporation(INCY) | COM | 45337C102 | $2.1B | 36,179,665 | 25.9% |
| BeiGene, Ltd.(ONC) | SPONSORED ADR | 07725L102 | $1.7B | 10,568,897 | 20.7% |
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $792.6M | 42,864,612 | 9.9% |
| Madrigal Pharmaceuticals, Inc.(MDGL) | COM | 558868105 | $526.0M | 1,969,798 | 6.6% |
| Rhythm Pharmaceuticals, Inc.(RYTM) | COM | 76243J105 | $277.2M | 6,398,365 | 3.5% |
| Revolution Medicines, Inc.(RVMD) | COM | 76155X100 | $243.3M | 7,549,249 | 3.1% |
| Kymera Therapeutics, Inc.(KYMR) | COM | 501575104 | $241.0M | 5,995,928 | 3.0% |
| AbCellera Biologics Inc.(ABCL) | COM | 00288U106 | $124.7M | 27,525,640 | 1.6% |
| Bicycle Therapeutics plc(BCYC) | SPONSORED ADS | 088786108 | $123.1M | 4,942,823 | 1.5% |
| Edgewise Therapeutics, Inc.(EWTX) | COM | 28036F105 | $106.5M | 5,840,059 | 1.3% |
| Immunocore Holdings plc(IMCR) | ADS | 45258D105 | $98.5M | 1,515,318 | 1.2% |
| Kodiak Sciences Inc.(KOD) | COM | 50015M109 | $91.1M | 17,310,490 | 1.1% |
| Roivant Sciences Ltd.(ROIV) | SHS | G76279101 | $78.1M | 7,413,834 | 1.0% |
| Replimune Group, Inc.(REPL) | COM | 76029N106 | $78.0M | 9,545,336 | 1.0% |
| Denali Therapeutics Inc.(DNLI) | COM | 24823R105 | $76.6M | 3,731,695 | 1.0% |
| Entrada Therapeutics, Inc.(TRDA) | COM | 29384C108 | $68.9M | 4,865,819 | 0.9% |
| Akero Therapeutics, Inc.(AKRO) | COM | 00973Y108 | $68.5M | 2,713,205 | 0.9% |
| Ultragenyx Pharmaceutical Inc.(RARE) | COM | 90400D108 | $68.5M | 1,466,547 | 0.9% |
| Immatics N.V.(IMTX) | SHS | N44445109 | $67.7M | 6,443,398 | 0.8% |
| Cerevel Therapeutics Holdings, Inc.(CERE1EUR) | COM | 15678U128 | $67.6M | 1,600,000 | 0.8% |
| argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $59.5M | 151,215 | 0.7% |
| Nurix Therapeutics, Inc.(NRIX) | COM | 67080M103 | $57.1M | 3,882,125 | 0.7% |
| Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | $55.4M | 2,809,577 | 0.7% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | COM | 09058V103 | $51.4M | 10,126,176 | 0.6% |
| Aerovate Therapeutics, Inc. | COM | 008064107 | $49.7M | 1,680,517 | 0.6% |
| Sera Prognostics, Inc.(SERA) | CLASS A COM | 81749D107 | $49.5M | 5,434,399 | 0.6% |
| Prelude Therapeutics Inc.(PRLD) | COM | 74065P101 | $48.0M | 10,123,824 | 0.6% |
| Ideaya Biosciences, Inc.(IDYA) | COM | 45166A102 | $46.6M | 1,062,123 | 0.6% |
| Stoke Therapeutics, Inc.(STOK) | COM | 86150R107 | $45.5M | 3,368,443 | 0.6% |
| Xenon Pharmaceuticals Inc.(XENE) | COM | 98420N105 | $42.8M | 993,679 | 0.5% |
| IGM Biosciences, Inc.(1K0) | COM | 449585108 | $39.5M | 4,088,322 | 0.5% |
| Cerus Corporation(CERS) | COM | 157085101 | $36.8M | 19,477,339 | 0.5% |
| Monte Rosa Therapeutics, Inc.(GLUE) | COM | 61225M102 | $34.7M | 4,916,095 | 0.4% |
| Celcuity Inc.(CELC) | COM | 15102K100 | $33.5M | 1,552,478 | 0.4% |
| Biomea Fusion, Inc.(BMEA) | COM | 09077A106 | $31.5M | 2,108,949 | 0.4% |
| Krystal Biotech, Inc.(KRYS) | COM | 501147102 | $30.2M | 169,934 | 0.4% |
| Sana Biotechnology, Inc.(SANA) | COM | 799566104 | $23.8M | 2,380,949 | 0.3% |
| Neurogene Inc.(NGNE) | COM | 64135M105 | $23.2M | 456,015 | 0.3% |
| Verve Therapeutics, Inc. | COM | 92539P101 | $22.5M | 1,691,530 | 0.3% |
| TScan Therapeutics, Inc.(TCRX) | COM | 89854M101 | $22.1M | 2,784,792 | 0.3% |
| Adaptimmune Therapeutics plc(ADAPY) | SPONSORED ADR | 00653A107 | $17.0M | 10,787,022 | 0.2% |
| Immunovant, Inc.(IMVT) | COM | 45258J102 | $13.7M | 425,009 | 0.2% |
| 2seventy bio, Inc.(TSVT*) | COMMON STOCK | 901384107 | $13.4M | 2,497,526 | 0.2% |
| Fate Therapeutics, Inc.(FATE) | COM | 31189P102 | $13.3M | 1,818,181 | 0.2% |
| Xencor, Inc.(XNCR) | COM | 98401F105 | $12.1M | 545,431 | 0.2% |
| Taysha Gene Therapies, Inc.(TSHA) | COM SHS | 877619106 | $11.5M | 4,004,756 | 0.1% |
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $10.9M | 14,614,264 | 0.1% |
| Celldex Therapeutics, Inc.(CLDX) | COM | 15117B202 | $10.4M | 247,644 | 0.1% |
| Relay Therapeutics, Inc.(RLAY) | COM | 75943R102 | $9.6M | 1,160,117 | 0.1% |
| Insmed Incorporated(INSM) | COM PAR $.01 | 457669307 | $9.3M | 343,000 | 0.1% |